PD1 Resistance with a Multi-Omic Approach
PharmaTalkRadio10 Mars 2020

PD1 Resistance with a Multi-Omic Approach

Anti-PD-1 therapy has transformed cancer care but most patients do not respond. It is increasingly clear that there will be no single biomarker of response to a PD-1, and that a multi-omic approach will be required. In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Danny Wells, Parker Institute for Cancer Immunotherapy will address: Orthogonality and correlation of response biomarkers across histologiesIntegration of multi-omic data sets for mechanistic insights into tumor immunobiologyThe translational approaches to PD1 resistance program at the Parker Institute To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
ufo-sverige
svd-nyhetsartiklar
det-morka-psyket
medicinvetarna
rss-vetenskapsradion
sexet
bildningspodden
halsorevolutionen
hacka-livet
naturmorgon
rss-vetenskapsradion-2
barnpsykologerna
ufo-sverige-2
rss-odla
rss-spraket
paranormalt-med-caroline-giertz
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap